-
1
-
-
9644297877
-
Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia
-
Abdelrahman M, Sharples EJ, McDonald MC, Collin M, Patel NS, Yaqoob MM, et al. (2004). Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 22: 63-69.
-
(2004)
Shock
, vol.22
, pp. 63-69
-
-
Abdelrahman, M.1
Sharples, E.J.2
McDonald, M.C.3
Collin, M.4
Patel, N.S.5
Yaqoob, M.M.6
-
2
-
-
4344626952
-
Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure
-
Bahlmann FH, Song R, Boehm SM, Mengel M, von Waseljewski R, Lindschau C, et al. (2004). Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 110: 1006-1012.
-
(2004)
Circulation
, vol.110
, pp. 1006-1012
-
-
Bahlmann, F.H.1
Song, R.2
Boehm, S.M.3
Mengel, M.4
Von Waseljewski, R.5
Lindschau, C.6
-
3
-
-
20044373442
-
Emerging biological roles for erythropoietin in the nervous system
-
Brines M, Cerami A, (2005). Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6: 484-494.
-
(2005)
Nat Rev Neurosci
, vol.6
, pp. 484-494
-
-
Brines, M.1
Cerami, A.2
-
4
-
-
33746137372
-
Discovering erythropoietin's extra-hematopoietic functions: Biological and clinical promise
-
Brines M, Cerami A, (2006). Discovering erythropoietin's extra-hematopoietic functions: biological and clinical promise. Kidney Int 70: 246-250.
-
(2006)
Kidney Int
, vol.70
, pp. 246-250
-
-
Brines, M.1
Cerami, A.2
-
5
-
-
0034641710
-
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
-
Brines M, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, et al. (2000). Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97: 10526-10531.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 10526-10531
-
-
Brines, M.1
Ghezzi, P.2
Keenan, S.3
Agnello, D.4
De Lanerolle, N.C.5
Cerami, C.6
-
6
-
-
6944237300
-
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
-
Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, et al. (2004). Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor. Proc Natl Acad Sci U S A 10: 14907-14912.
-
(2004)
Proc Natl Acad Sci U S A
, vol.10
, pp. 14907-14912
-
-
Brines, M.1
Grasso, G.2
Fiordaliso, F.3
Sfacteria, A.4
Ghezzi, P.5
Fratelli, M.6
-
7
-
-
0037447256
-
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
-
Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, et al. (2003). Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A 100: 4802-4806.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 4802-4806
-
-
Calvillo, L.1
Latini, R.2
Kajstura, J.3
Leri, A.4
Anversa, P.5
Ghezzi, P.6
-
8
-
-
1842457002
-
Chemical modifications on proteins using glutaraldehyde
-
Carla JSM, Fernanda S, Georg G, Artur C-P, (2004). Chemical modifications on proteins using glutaraldehyde. Food Technol Biotechnol 42: 51-56.
-
(2004)
Food Technol Biotechnol
, vol.42
, pp. 51-56
-
-
Carla, J.S.M.1
Fernanda, S.2
Georg, G.3
Artur, C.-P.4
-
9
-
-
7944222978
-
Science review: Recombinant human erythropoietin in critical illness: A role beyond anemia?
-
Coleman T, Brines M, (2004). Science review: recombinant human erythropoietin in critical illness: a role beyond anemia? Crit Care 8: 337-341.
-
(2004)
Crit Care
, vol.8
, pp. 337-341
-
-
Coleman, T.1
Brines, M.2
-
10
-
-
33645827977
-
Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different pro-coagulant and vasoactive activities
-
Coleman TR, Westenfelder C, Tögel FE, Yang Y, Hu Z, Swenson L, et al. (2006). Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different pro-coagulant and vasoactive activities. Proc Natl Acad Sci U S A 103: 5965-5970.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 5965-5970
-
-
Coleman, T.R.1
Westenfelder, C.2
Tögel, F.E.3
Yang, Y.4
Hu, Z.5
Swenson, L.6
-
11
-
-
21444442363
-
Biosimilar epoetins: An analysis based on recently implemented European medicines evaluation agency guidelines on comparability of biopharmaceutical proteins
-
Combe C, Tredree RL, Schellekens H, (2005). Biosimilar epoetins: an analysis based on recently implemented European medicines evaluation agency guidelines on comparability of biopharmaceutical proteins. Pharmacotherapy 25: 954-962.
-
(2005)
Pharmacotherapy
, vol.25
, pp. 954-962
-
-
Combe, C.1
Tredree, R.L.2
Schellekens, H.3
-
12
-
-
0019333228
-
Stabilization of protein by guanidination
-
Cupo P, EI-Deiry W, Whitney PL, Awad WM, (1980). Stabilization of protein by guanidination. J Biol Chem 255: 10828-10833.
-
(1980)
J Biol Chem
, vol.255
, pp. 10828-10833
-
-
Cupo, P.1
Ei-Deiry, W.2
Whitney, P.L.3
Awad, W.M.4
-
13
-
-
33748921915
-
Biophysical comparability of the same protein from different manufacturers: A case study using epoetin alfa from epogen and eprex
-
Deechongkit S, Aoki KH, Park SS, Kerwin BA, (2006). Biophysical comparability of the same protein from different manufacturers: a case study using epoetin alfa from epogen and eprex. J Pharm Sci 95: 1931-1943.
-
(2006)
J Pharm Sci
, vol.95
, pp. 1931-1943
-
-
Deechongkit, S.1
Aoki, K.H.2
Park, S.S.3
Kerwin, B.A.4
-
14
-
-
0035833541
-
Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kB signaling cascades
-
Digicaylioglu M, Lipton SA, (2001). Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kB signaling cascades. Nature 412: 641-647.
-
(2001)
Nature
, vol.412
, pp. 641-647
-
-
Digicaylioglu, M.1
Lipton, S.A.2
-
15
-
-
0014325267
-
Reversible blocking of amino groups with citraconic anhydride
-
Dixon HBF, Perham RN, (1968). Reversible blocking of amino groups with citraconic anhydride. Biochem J 109: 312-314.
-
(1968)
Biochem J
, vol.109
, pp. 312-314
-
-
Dixon, H.B.F.1
Perham, R.N.2
-
16
-
-
0033590630
-
Hydrogen peroxide-induced apoptosis is CD 95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappa B
-
Dumont A, (1999). Hydrogen peroxide-induced apoptosis is CD 95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappa B. Oncogene 18: 747-757.
-
(1999)
Oncogene
, vol.18
, pp. 747-757
-
-
Dumont, A.1
-
17
-
-
0015115320
-
The measurement of amino groups in proteins and peptides
-
Fields R, (1971). The measurement of amino groups in proteins and peptides. Biochem J 124: 581-590.
-
(1971)
Biochem J
, vol.124
, pp. 581-590
-
-
Fields, R.1
-
18
-
-
13844320400
-
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury
-
Fiordaliso F, Chimenti S, Staszewsky L, Bai A, Carlo E, Cuccovillo I, et al. (2005). A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci U S A 102: 2046-2051.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 2046-2051
-
-
Fiordaliso, F.1
Chimenti, S.2
Staszewsky, L.3
Bai, A.4
Carlo, E.5
Cuccovillo, I.6
-
19
-
-
0037227316
-
Erythropoietin: Physiology and pharmacology update
-
Fisher JW, (2003). Erythropoietin: physiology and pharmacology update. Exp Biol Med 228: 1-14.
-
(2003)
Exp Biol Med
, vol.228
, pp. 1-14
-
-
Fisher, J.W.1
-
20
-
-
0027288347
-
Activation of apoptosis by serum deprivation in a teratocarcinoma cell line: Inhibition by L-acetylcarnitine
-
Galli G, Fratelli M, (1993). Activation of apoptosis by serum deprivation in a teratocarcinoma cell line: inhibition by L-acetylcarnitine. Exp Cell Res 204: 54-60.
-
(1993)
Exp Cell Res
, vol.204
, pp. 54-60
-
-
Galli, G.1
Fratelli, M.2
-
21
-
-
3242772957
-
EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney
-
Gong H, Wang W, Kwon TH, Jonassen T, Li C, Ring T, et al. (2004). EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney Int 66: 683-695.
-
(2004)
Kidney Int
, vol.66
, pp. 683-695
-
-
Gong, H.1
Wang, W.2
Kwon, T.H.3
Jonassen, T.4
Li, C.5
Ring, T.6
-
22
-
-
0037047154
-
Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma
-
Gorio A, Gokmen N, Erbayraktar S, Yilmaz O, Madaschi L, Cichetti C, et al. (2002). Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci U S A 99: 9450-9455.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 9450-9455
-
-
Gorio, A.1
Gokmen, N.2
Erbayraktar, S.3
Yilmaz, O.4
Madaschi, L.5
Cichetti, C.6
-
23
-
-
0000529593
-
Molecular structural effects produced in proteins by reaction with succinic anhydride
-
Habeeb AF, Cassidy HG, Singer SG, (1958). Molecular structural effects produced in proteins by reaction with succinic anhydride. Biochem Biophys Acta 29: 587-593.
-
(1958)
Biochem Biophys Acta
, vol.29
, pp. 587-593
-
-
Habeeb, A.F.1
Cassidy, H.G.2
Singer, S.G.3
-
24
-
-
0026514620
-
Carbamylation-induced alterations in low-density lipoprotein mechanism
-
Horkko S, Savolainen MJ, Kervinen K, Kesaniemi YA, (1992). Carbamylation-induced alterations in low-density lipoprotein mechanism. Kidney Int 4: 1175-1181.
-
(1992)
Kidney Int
, vol.4
, pp. 1175-1181
-
-
Horkko, S.1
Savolainen, M.J.2
Kervinen, K.3
Kesaniemi, Y.A.4
-
25
-
-
33845979434
-
Carbamylated erythropoietin protects the kidney from ischemia-reperfusion injury without stimulating erythropoiesis
-
Imamura R, Isaka Y, Ichimaru N, Takahara S, Okuyama A, (2007). Carbamylated erythropoietin protects the kidney from ischemia-reperfusion injury without stimulating erythropoiesis. Biochem Biophys Res Commun 353: 786-792.
-
(2007)
Biochem Biophys Res Commun
, vol.353
, pp. 786-792
-
-
Imamura, R.1
Isaka, Y.2
Ichimaru, N.3
Takahara, S.4
Okuyama, A.5
-
26
-
-
36049007201
-
Recombinant EPO production points the nephrologist should know
-
Jelkmann W, (2007). Recombinant EPO production points the nephrologist should know. Nephrol Dial Transplant 22: 2749-2753.
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 2749-2753
-
-
Jelkmann, W.1
-
27
-
-
58549098542
-
'O', erythropoietin carbamoylation versus carbamylation
-
Jelkmann W, (2008). 'O', erythropoietin carbamoylation versus carbamylation. Nephrol Dial Transplant 23: 3033.
-
(2008)
Nephrol Dial Transplant
, vol.23
, pp. 3033
-
-
Jelkmann, W.1
-
28
-
-
7444253390
-
Beneficial and ominous aspects of the pleiotropic action of erythropoietin
-
Jelkmann W, Wagner K, (2004). Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Ann Hematol 83: 673-686.
-
(2004)
Ann Hematol
, vol.83
, pp. 673-686
-
-
Jelkmann, W.1
Wagner, K.2
-
29
-
-
0036678821
-
Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury
-
Junk AK, Mammis A, Savitz SI, Singh M, Roth S, Malhotra S, et al. (2002). Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A 99: 10659-10664.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 10659-10664
-
-
Junk, A.K.1
Mammis, A.2
Savitz, S.I.3
Singh, M.4
Roth, S.5
Malhotra, S.6
-
30
-
-
33644990074
-
Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking
-
Kawaguchi Y, Ito A, Appella E, Yao T, (2006). Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking. J Biol Chem 281: 1394-1400.
-
(2006)
J Biol Chem
, vol.281
, pp. 1394-1400
-
-
Kawaguchi, Y.1
Ito, A.2
Appella, E.3
Yao, T.4
-
31
-
-
77954326944
-
NC3Rs Reporting Guidelines Working Group
-
Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 1577-1579
-
-
Kilkenny, C.1
Browne, W.2
Cuthill, I.C.3
Emerson, M.4
Altman, D.G.5
-
32
-
-
0034674703
-
Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells
-
Kim H, Lee TH, Park ES, Suh JM, Park SJ, Chung HK, et al. (2000). Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 275: 18266-18270.
-
(2000)
J Biol Chem
, vol.275
, pp. 18266-18270
-
-
Kim, H.1
Lee, T.H.2
Park, E.S.3
Suh, J.M.4
Park, S.J.5
Chung, H.K.6
-
33
-
-
34447118238
-
Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat
-
King VR, Averill SA, Hewazy D, Priestley JV, Torup L, Michael-Titus AT, (2007). Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur J Neurosci 26: 90-100.
-
(2007)
Eur J Neurosci
, vol.26
, pp. 90-100
-
-
King, V.R.1
Averill, S.A.2
Hewazy, D.3
Priestley, J.V.4
Torup, L.5
Michael-Titus, A.T.6
-
34
-
-
0031755934
-
Biological of erythropoietin
-
Lacombe C, Mayeux P, (1998). Biological of erythropoietin. Haematologica 83: 724-732.
-
(1998)
Haematologica
, vol.83
, pp. 724-732
-
-
Lacombe, C.1
Mayeux, P.2
-
35
-
-
0032916880
-
The molecular biological of erythropoietin
-
Lacombe C, Mayeux P, (1999). The molecular biological of erythropoietin. Nephrol Dial Transplant 14 (Suppl 2): 22-28.
-
(1999)
Nephrol Dial Transplant
, vol.14
, Issue.SUPPL. 2
, pp. 22-28
-
-
Lacombe, C.1
Mayeux, P.2
-
36
-
-
3042725549
-
Derivatives of erythropoietin that are tissue protective but not erythropoietic
-
Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, et al. (2004). Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239-242.
-
(2004)
Science
, vol.305
, pp. 239-242
-
-
Leist, M.1
Ghezzi, P.2
Grasso, G.3
Bianchi, R.4
Villa, P.5
Fratelli, M.6
-
37
-
-
44449179744
-
Salvianolic Acid B Inhibits Hydrogen Peroxide-Induced Endothelial Cell Apoptosis through Regulating PI3K/Akt Signaling
-
Liu CL, Xie LX, Li M, Durairajan SSK, Goto S, Huan JD, (2007). Salvianolic Acid B Inhibits Hydrogen Peroxide-Induced Endothelial Cell Apoptosis through Regulating PI3K/Akt Signaling. Plos ONE 19: e1321.
-
(2007)
Plos ONE
, vol.19
-
-
Liu, C.L.1
Xie, L.X.2
Li, M.3
Durairajan, S.S.K.4
Goto, S.5
Huan, J.D.6
-
38
-
-
0010482868
-
The modification of lysine
-
Lundblad R.L. Noyes C.M. (eds). CRC Press: Boca Raton, FL
-
Lundblad RL, Noyes CM, (1984). The modification of lysine. In:, Lundblad RL, Noyes CM, (eds). Chemical Reagent for Protein Modification. CRC Press: Boca Raton, FL, pp. 127-170.
-
(1984)
Chemical Reagent for Protein Modification
, pp. 127-170
-
-
Lundblad, R.L.1
Noyes, C.M.2
-
39
-
-
11244333356
-
New avenues of exploration for erythropoietin
-
Maiese K, Li F, Chong ZZ, (2005). New avenues of exploration for erythropoietin. JAMA 293: 90-95.
-
(2005)
JAMA
, vol.293
, pp. 90-95
-
-
Maiese, K.1
Li, F.2
Chong, Z.Z.3
-
40
-
-
20144386806
-
A biologic role of HIF-1 in the renal medulla
-
Manotham K, Tanaka T, Ohse T, Kojima I, Miyata T, Inagi R, et al. (2005). A biologic role of HIF-1 in the renal medulla. Kidney Int 67: 1428-1439.
-
(2005)
Kidney Int
, vol.67
, pp. 1428-1439
-
-
Manotham, K.1
Tanaka, T.2
Ohse, T.3
Kojima, I.4
Miyata, T.5
Inagi, R.6
-
41
-
-
0029976021
-
Erythropoietin gene expression in human, monkey and murine brain
-
Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, et al. (1996). Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 8: 666-676.
-
(1996)
Eur J Neurosci
, vol.8
, pp. 666-676
-
-
Marti, H.H.1
Wenger, R.H.2
Rivas, L.A.3
Straumann, U.4
Digicaylioglu, M.5
Henn, V.6
-
42
-
-
77954331629
-
Guidelines for reportingexperiments involving animals: The ARRIVE guidelines
-
(2010).
-
McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reportingexperiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
-
Br J Pharmacol
, vol.160
, pp. 1573-1576
-
-
McGrath, J.1
Drummond, G.2
McLachlan, E.3
Kilkenny, C.4
Wainwright, C.5
-
43
-
-
34447290901
-
The continuous erythropoietin receptor activator affects different pathways of diabetic renal injury
-
Menne J, Park JK, Shushakova N, Mengel M, Meier M, Fliser D, (2007). The continuous erythropoietin receptor activator affects different pathways of diabetic renal injury. J Am Soc Nephrol 18: 2046-2053.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 2046-2053
-
-
Menne, J.1
Park, J.K.2
Shushakova, N.3
Mengel, M.4
Meier, M.5
Fliser, D.6
-
44
-
-
33750487504
-
Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo
-
Mennini T, De Paola M, Bigini P, Mastrotto C, Fumagalli E, Barbera S, et al. (2006). Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo. Mol Med 12: 153-160.
-
(2006)
Mol Med
, vol.12
, pp. 153-160
-
-
Mennini, T.1
De Paola, M.2
Bigini, P.3
Mastrotto, C.4
Fumagalli, E.5
Barbera, S.6
-
45
-
-
0017125959
-
N-acetylbenzotriazole as a protein reagent
-
Michèle RR, Charis G, (1976). N-acetylbenzotriazole as a protein reagent. Eur J Biochem 65: 25-33.
-
(1976)
Eur J Biochem
, vol.65
, pp. 25-33
-
-
Michèle, R.R.1
Charis, G.2
-
46
-
-
33644775862
-
Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties
-
Moon C, Krawczyk M, Paik D, Coleman T, Brines M, Juhaszova M, et al. (2006). Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties. J Pharmacol Exp Ther 316: 999-1005.
-
(2006)
J Pharmacol Exp Ther
, vol.316
, pp. 999-1005
-
-
Moon, C.1
Krawczyk, M.2
Paik, D.3
Coleman, T.4
Brines, M.5
Juhaszova, M.6
-
47
-
-
0030636320
-
Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death
-
Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R, (1997). Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76: 105-116.
-
(1997)
Neuroscience
, vol.76
, pp. 105-116
-
-
Morishita, E.1
Masuda, S.2
Nagao, M.3
Yasuda, Y.4
Sasaki, R.5
-
48
-
-
0030831330
-
Apoptotic cell death in neuronal differentiation of P19 EC cells: Cell death follows reentry into S phase
-
Ninomiya Y, Adams R, Morriss-Kay GM, Eto K, (1997). Apoptotic cell death in neuronal differentiation of P19 EC cells: cell death follows reentry into S phase. J Cell Physiol 172: 25-35.
-
(1997)
J Cell Physiol
, vol.172
, pp. 25-35
-
-
Ninomiya, Y.1
Adams, R.2
Morriss-Kay, G.M.3
Eto, K.4
-
49
-
-
33646911359
-
Role of parathyroid hormone-related protein in tubulointerstitial apoptosis and fibrosis after folic acid-induced nephrotoxicity
-
Ortega A, Rámila D, Ardura JA, Esteban V, Ruiz-Ortega M, Barat A, et al. (2006). Role of parathyroid hormone-related protein in tubulointerstitial apoptosis and fibrosis after folic acid-induced nephrotoxicity. J Am Soc Nephrol 17: 1594-1603.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 1594-1603
-
-
Ortega, A.1
Rámila, D.2
Ardura, J.A.3
Esteban, V.4
Ruiz-Ortega, M.5
Barat, A.6
-
50
-
-
1242272769
-
Inhibition of erythropoietin activity by cyanate
-
Park KD, Mun KC, Chang EJ, Park SB, Kim HC, (2004). Inhibition of erythropoietin activity by cyanate. Scand J Urol Nephrol 38: 69-72.
-
(2004)
Scand J Urol Nephrol
, vol.38
, pp. 69-72
-
-
Park, K.D.1
Mun, K.C.2
Chang, E.J.3
Park, S.B.4
Kim, H.C.5
-
51
-
-
4344675279
-
Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo
-
Patel NS, Sharples EJ, Cuzzocrea S, Chatterjee PK, Britti D, Yaqoob MM, et al. (2004). Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 66: 983-989.
-
(2004)
Kidney Int
, vol.66
, pp. 983-989
-
-
Patel, N.S.1
Sharples, E.J.2
Cuzzocrea, S.3
Chatterjee, P.K.4
Britti, D.5
Yaqoob, M.M.6
-
52
-
-
0028180569
-
JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region
-
Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, et al. (1994). JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14: 4335-4341.
-
(1994)
Mol Cell Biol
, vol.14
, pp. 4335-4341
-
-
Quelle, F.W.1
Sato, N.2
Witthuhn, B.A.3
Inhorn, R.C.4
Eder, M.5
Miyajima, A.6
-
53
-
-
0014409413
-
Carbamylation of pepsinogen and pepsin
-
Rimon S, Perlmann G, (1968). Carbamylation of pepsinogen and pepsin. J Biol Chem 243: 3566-3572.
-
(1968)
J Biol Chem
, vol.243
, pp. 3566-3572
-
-
Rimon, S.1
Perlmann, G.2
-
54
-
-
0025253474
-
Chemical modification of erythropoietin: An increase in in vivo activity by guanidination
-
Satake R, Kozutsumi H, Takeuchi M, Asano K, (1990). Chemical modification of erythropoietin: an increase in in vivo activity by guanidination. Biochim Biophys Acta 1038: 125-129.
-
(1990)
Biochim Biophys Acta
, vol.1038
, pp. 125-129
-
-
Satake, R.1
Kozutsumi, H.2
Takeuchi, M.3
Asano, K.4
-
55
-
-
32944459736
-
Factors influencing the immunogenicity of therapeutic proteins
-
Schellekens H, (2005). Factors influencing the immunogenicity of therapeutic proteins. Nephrol Dial Transplant 20 (Suppl 6): 3-9.
-
(2005)
Nephrol Dial Transplant
, vol.20
, Issue.SUPPL. 6
, pp. 3-9
-
-
Schellekens, H.1
-
56
-
-
3543097510
-
Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion
-
Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, et al. (2004). Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 15: 2115-2124.
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 2115-2124
-
-
Sharples, E.J.1
Patel, N.2
Brown, P.3
Stewart, K.4
Mota-Philipe, H.5
Sheaff, M.6
-
57
-
-
0035957426
-
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
-
Sirén AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, et al. (2001). Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 98: 4044-4049.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 4044-4049
-
-
Sirén, A.L.1
Fratelli, M.2
Brines, M.3
Goemans, C.4
Casagrande, S.5
Lewczuk, P.6
-
58
-
-
31544472841
-
Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model
-
Spandou E, Tsouchnikas I, Karkavelas G, Dounousi E, Simeonidou C, Guiba-Tziampiri O, et al. (2006). Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant 21: 330-336.
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 330-336
-
-
Spandou, E.1
Tsouchnikas, I.2
Karkavelas, G.3
Dounousi, E.4
Simeonidou, C.5
Guiba-Tziampiri, O.6
-
59
-
-
1042292029
-
Erythropoietin protects against ischemic acute renal injury
-
Vesey DA, Cheung C, Pat B, Endre Z, Gobé G, Johnson DW, (2004). Erythropoietin protects against ischemic acute renal injury. Nephrol Dial Transplant 19: 348-355.
-
(2004)
Nephrol Dial Transplant
, vol.19
, pp. 348-355
-
-
Vesey, D.A.1
Cheung, C.2
Pat, B.3
Endre, Z.4
Gobé, G.5
Johnson, D.W.6
-
60
-
-
23744466195
-
Interaction of polysorbate 80 with erythropoietin: A case study in protein-surfactant interactions
-
Villalobos AP, Gunturi SR, Heavner GA, (2005). Interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions. Pharm Res 22: 1186-1194.
-
(2005)
Pharm Res
, vol.22
, pp. 1186-1194
-
-
Villalobos, A.P.1
Gunturi, S.R.2
Heavner, G.A.3
-
61
-
-
33748707376
-
European regulatory guidelines for biosimilars
-
Wiecek A, Mikhail A, (2006). European regulatory guidelines for biosimilars. Nephrol Dial Transplant 21 (Suppl 5): 17-20.
-
(2006)
Nephrol Dial Transplant
, vol.21
, Issue.SUPPL. 5
, pp. 17-20
-
-
Wiecek, A.1
Mikhail, A.2
-
62
-
-
0141595004
-
Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney
-
Yang CW, Li C, Jung JY, Shin SJ, Choi BS, Lim SW, et al. (2003). Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 17: 1754-1755.
-
(2003)
FASEB J
, vol.17
, pp. 1754-1755
-
-
Yang, C.W.1
Li, C.2
Jung, J.Y.3
Shin, S.J.4
Choi, B.S.5
Lim, S.W.6
|